James R.

James R. is a skilled professional with a strong background in the biotech and pharmaceutical industry. With extensive experience in leadership roles at various companies like WEHI, Kling Biotherapeutics, and Novartis, James has a proven track record of success in driving innovation and growth. Their expertise in translational research, drug development, and organizational strategy make him a valuable asset in the field. James holds a Ph.D in Immunology from the University of Sydney and has furthered their education with a Postdoctoral Fellowship at Yale University and an Executive Masters from The London School of Economics and Political Science.